The global flow cytometry market size was valued at USD 3.27 billion in 2016 and is expected to grow at a CAGR of 10.6% over the forecast period. Key drivers include rising prevalence of chronic diseases, which needs toxicity testing such as cancer tests and demand for rapid, accurate, & sensitive prognosis techniques for disease validation.
Growing awareness level amongst patients and healthcare professionals and high level of healthcare expenditure are high-rendering drivers for flow cytometry industry growth. Furthermore, associated advantages of cell-based assays such as ease-of-use, high sensitivity & reproductively, and advancement in reagents & software used for the analysis are other factors expected to drive the growth.
U.S. flow cytometry market, by application, 2014-2025 (USD Million)
Cell-based flow cytometry dominated the overall market. Increasing demand for early diagnosis and rising awareness pertaining to associated benefits with cell-based assays are the factors attributing to its dominance over the forecast period.
Cell-based flow cytometry has extensive applications in various research fields. These assays are used in drug discovery for the physiological significance of the results. In addition, it is used in clinical studies including tumor cells in peripheral blood, endothelial cells in blood, tumor stem cells, and hematopoietic progenitor cells. Furthermore, they are used in the study of disease mechanism and target identification.
The instrument segment dominated the market in 2016 owing to greater penetration coupled with advantages such as accurate result, cost-effective nature, and user-friendliness. Reagents and consumables, owing to their increased usage in cancer diagnostics are expected to register lucrative growth.
The instruments used for flow cytometry are cell analyzers, cell sorters, and sample preparation devices such as platforms for cell analysis & replaceable components like filters, lasers, and detectors. The introduction of novel technologies such as multicolor flow cytometers coupled with the capability to detect upto 18 cell parameters simultaneously is one of the factors contributing toward growth.
Flow cytometry has applications in research, clinical diagnosis, and industrial sectors. Research segment dominated in 2016 owing to an increasing R&D pertaining to cancer and other infectious diseases. Flow cytometry also has applications in various industries such as food microbiology and plant tissue culture.
Clinical diagnosis is expected to be the fastest growing application segment by 2025. Clinical diagnosis market is driven by factors such as increasing demand for cost-effective disease diagnostic tools and associated benefits of these assays in disease detection.
The commercial organization segment held the largest revenue share owing to wide applications across various verticals such as food microbiology, blood banks, and plant cell culture. The introduction of multiplex probes and reagents for specific applications in diagnostics & drug discovery is expected to serve this vertical with growth opportunities by catering to the users in research and small peripheral laboratories.
Hospitals are expected to grow at lucrative CAGR due to increasing diagnostic tests necessitated by rising prevalence of chronic & infectious diseases, supportive reimbursement policies, and growing awareness amongst patients.
North America dominated the overall flow cytometry Industry in 2016 due to the presence of supportive government reforms for the development of advanced technologies for molecular diagnostics. In addition, availability of skilled professionals and higher awareness level are some of the factors anticipated to boost the regional market growth.
Global flow cytometry market share, by end-use, 2016 (%)
Asia Pacific region is presumed to show lucrative growth in the coming years owing to increasing supportive government funding for biotech industry development. The presence of untapped opportunities, constantly improving healthcare infrastructure, economic development, and rising patient awareness levels are some of the factors accounting for the rapid growth of this region.
Some of the key players operating in this industry are Beckman Coulter, Inc.; Becton, Dickinson and Company; Sysmex Corporation; Agilent Technologies; Merck & Co., Inc., Apogee Flow Systems Ltd.; Bio-Rad Laboratories, Inc.; Thermo Fisher Scientific, Stratedigm, Inc.; Luminex Corporation; Miltenyi Biotec; and GE Healthcare.
The market is competitive in nature as key players are involved in continuous product development and partnership alliances to aid market penetration. Arising number of outsourcing service providers are expected to increase industry rivalry in the near future. Industry players are gaining market penetration by setting up manufacturing plants in untapped regions of developing countries. For instance, in September 2015, BD Life Sciences entered into a collaborative agreement with Seegene Inc. for the development of multiplex real-time PCR reagents for the BD max system in a probe to gain more share.
|
Attribute |
Details |
|
Base year for estimation |
2016 |
|
Actual estimates/Historical data |
2014 - 2016 |
|
Forecast period |
2017 - 2025 |
|
Market representation |
Revenue in USD Million & CAGR from 2017 to 2025 |
|
Regional scope |
North America, Europe, Asia-Pacific, Latin America & MEA |
|
Country scope |
U.S., Canada, UK, Germany, France, Japan, China, Brazil, Mexico, South Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
|
15% free customization scope (equivalent to 5 analyst working days) |
If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization |
This report forecasts revenue growth and provides an analysis of the industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the flow cytometry market on the basis of technology, product & services application, end-use, and region:
Technology Outlook (Revenue, USD Million, 2014 - 2025)
Cell based
Bead based
Product & Services Outlook (Revenue, USD Million, 2014 - 2025)
Instruments
Reagent & consumables
Software
Accessories
services
Application Outlook (Revenue, USD Million, 2014 - 2025)
Research
Pharmaceutical
Drug discovery
Stem cells
In vitro toxicity
Apoptosis
Cell sorting
Cell cycle analysis
Immunology
Cell viability
Industrial
Clinical
Cancer
Organ transplantation
Immunodeficiency
Hematology
End-use Outlook (Revenue, USD Million, 2014 - 2025)
Commercial organizations
Hospitals
Academic institutes
Clinical testing labs
Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
The Middle East and Africa
South Africa
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."
